- Home
- LVO vs MCRB Comparison
LVO vs MCRB Comparison
Compare LVO & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LVO | MCRB |
|---|---|---|
| Founded | 2009 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.7M | 71.0M |
| IPO Year | 2010 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LVO | MCRB |
|---|---|---|
| Price | $5.14 | $5.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $11.50 | ★ $14.00 |
| AVG Volume (30 Days) | 68.6K | ★ 128.6K |
| Earning Date | 06-17-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.57 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $77,144,000.00 | $789,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.43 | $5.31 |
| 52 Week High | $7.19 | $29.98 |
Technical Indicators
Market Signals| Indicator | LVO | MCRB |
|---|---|---|
| Relative Strength Index (RSI) | 42.53 | 30.53 |
| Support Level | $4.09 | N/A |
| Resistance Level | $5.77 | $9.53 |
| Average True Range (ATR) | 0.53 | 0.65 |
| MACD | -0.09 | -0.21 |
| Stochastic Oscillator | 35.18 | 3.12 |
Price Performance
Historical ComparisonAbout LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.